Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Apr 11;92(8):3439-43.
doi: 10.1073/pnas.92.8.3439.

Prostate cancer in a transgenic mouse

Affiliations

Prostate cancer in a transgenic mouse

N M Greenberg et al. Proc Natl Acad Sci U S A. .

Abstract

Progress toward understanding the biology of prostate cancer has been slow due to the few animal research models available to study the spectrum of this uniquely human disease. To develop an animal model for prostate cancer, several lines of transgenic mice were generated by using the prostate-specific rat probasin promoter to derive expression of the simian virus 40 large tumor antigen-coding region. Mice expressing high levels of the transgene display progressive forms of prostatic disease that histologically resemble human prostate cancer, ranging from mild intraepithelial hyperplasia to large multinodular malignant neoplasia. Prostate tumors have been detected specifically in the prostate as early as 10 weeks of age. Immunohistochemical analysis of tumor tissue has demonstrated that dorsolateral prostate-specific secretory proteins were confined to well-differentiated ductal epithelial cells adjacent to, or within, the poorly differentiated tumor mass. Prostate tumors in the mice also display elevated levels of nuclear p53 and a decreased heterogeneous pattern of androgen-receptor expression, as observed in advanced human prostate cancer. The establishment of breeding lines of transgenic mice that reproducibly develop prostate cancer provides an animal model system to study the molecular basis of transformation of normal prostatic cells and the factors influencing the progression to metastatic prostate cancer.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Natl Cancer Inst. 1973 Oct;51(4):1235-41 - PubMed
    1. Cancer Res. 1994 May 15;54(10):2577-81 - PubMed
    1. Cancer Res. 1977 Jun;37(6):1929-33 - PubMed
    1. Nature. 1979 Mar 15;278(5701):261-3 - PubMed
    1. Cell. 1979 May;17(1):43-52 - PubMed

Publication types

MeSH terms

-